Annual report
4480.TEDINET S100VGHP
Period2024-01-01 → 2024-12-31
Filed2025-03-25
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 153
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥29.3bn | 2024-01-01 → 2024-12-31 | Cons. | Net sales |
| Revenue | ¥20.5bn | 2023-01-01 → 2023-12-31 | Cons. | Net sales |
| Revenue | ¥14.2bn | 2022-01-01 → 2022-12-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥10.9bn | 2021-01-01 → 2021-12-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥6.8bn | 2020-01-01 → 2020-12-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥2.3bn | 2024-01-01 → 2024-12-31 | Cons. | Operating income |
| Operating income | ¥2.7bn | 2023-01-01 → 2023-12-31 | Cons. | Operating income |
| Ordinary income | ¥4.1bn | 2024-01-01 → 2024-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥3.8bn | 2023-01-01 → 2023-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.5bn | 2022-01-01 → 2022-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥743m | 2021-01-01 → 2021-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥422m | 2020-01-01 → 2020-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥4.1bn | 2024-01-01 → 2024-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥3.8bn | 2023-01-01 → 2023-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥2.8bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.6bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.0bn | 2022-01-01 → 2022-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥563m | 2021-01-01 → 2021-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥455m | 2020-01-01 → 2020-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥2.8bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss |
| Net income | ¥2.6bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss |
| Total assets | ¥45.2bn | at 2024-12-31 | Cons. | Assets |
| Total assets | ¥25.4bn | at 2023-12-31 | Cons. | Assets |
| Total assets | ¥21.8bn | at 2022-12-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥20.2bn | at 2021-12-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥15.5bn | at 2020-12-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥25.0bn | at 2024-12-31 | Cons. | Liabilities |
| Total liabilities | ¥7.8bn | at 2023-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥20.2bn | at 2024-12-31 | Cons. | Net assets |
| Net assets / equity | ¥17.6bn | at 2023-12-31 | Cons. | Net assets |
| Net assets / equity | ¥15.2bn | at 2022-12-31d | Cons. | Net assets |
| Net assets / equity | ¥14.0bn | at 2021-12-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥9.7bn | at 2020-12-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥19.0bn | at 2024-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥15.4bn | at 2023-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥19.0bn | at 2024-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥15.4bn | at 2023-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥14.4bn | at 2022-12-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥14.0bn | at 2021-12-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥14.1bn | at 2020-12-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥2.4bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥3.9bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.0bn | 2022-01-01 → 2022-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.0bn | 2021-01-01 → 2021-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥805m | 2020-01-01 → 2020-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥10.7bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.7bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥751m | 2022-01-01 → 2022-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥3.3bn | 2021-01-01 → 2021-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥283m | 2020-01-01 → 2020-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥11.9bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥1.2bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥927m | 2022-01-01 → 2022-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥2.2bn | 2021-01-01 → 2021-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥9.1bn | 2020-01-01 → 2020-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥86.17 | 2024-01-01 → 2024-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥79.53 | 2023-01-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥31.77 | 2022-01-01 → 2022-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥17.79 | 2021-01-01 → 2021-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥15.69 | 2020-01-01 → 2020-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥85.62 | 2024-01-01 → 2024-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥78.55 | 2023-01-01 → 2023-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥31.16 | 2022-01-01 → 2022-12-31d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥17.15 | 2021-01-01 → 2021-12-31d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥14.48 | 2020-01-01 → 2020-12-31d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥621.43 | at 2024-12-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥542.49 | at 2023-12-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥469.79 | at 2022-12-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥438.43 | at 2021-12-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥314.53 | at 2020-12-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 44.7% | at 2024-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 69.0% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 69.1% | at 2022-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 69.1% | at 2021-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 62.6% | at 2020-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 14.7% | 2024-01-01 → 2024-12-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 15.8% | 2023-01-01 → 2023-12-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.0% | 2022-01-01 → 2022-12-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 4.7% | 2021-01-01 → 2021-12-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.0% | 2020-01-01 → 2020-12-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 1,487 | at 2024-12-31 | Cons. | Number of employees |
| Employees | 1,105 | at 2023-12-31 | Cons. | Number of employees |
| Employees | 895 | at 2022-12-31d | Cons. | Number of employees |
| Employees | 719 | at 2021-12-31d | Cons. | Number of employees |
| Employees | 494 | at 2020-12-31d | Cons. | Number of employees |
| Revenue | ¥20.9bn | 2024-01-01 → 2024-12-31 | Standalone | Net sales |
| Revenue | ¥16.4bn | 2023-01-01 → 2023-12-31 | Standalone | Net sales |
| Revenue | ¥11.6bn | 2022-01-01 → 2022-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥9.0bn | 2021-01-01 → 2021-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥6.7bn | 2020-01-01 → 2020-12-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥2.7bn | 2024-01-01 → 2024-12-31 | Standalone | Operating income |
| Operating income | ¥2.8bn | 2023-01-01 → 2023-12-31 | Standalone | Operating income |
| Ordinary income | ¥4.6bn | 2024-01-01 → 2024-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥3.9bn | 2023-01-01 → 2023-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥1.7bn | 2022-01-01 → 2022-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥770m | 2021-01-01 → 2021-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥433m | 2020-01-01 → 2020-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥4.1bn | 2024-01-01 → 2024-12-31 | Standalone | Income before income taxes |
| Profit before tax | ¥3.9bn | 2023-01-01 → 2023-12-31 | Standalone | Income before income taxes |
| Net income | ¥3.1bn | 2024-01-01 → 2024-12-31 | Standalone | Profit loss |
| Net income | ¥2.7bn | 2023-01-01 → 2023-12-31 | Standalone | Profit loss |
| Net income | ¥1.2bn | 2022-01-01 → 2022-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥653m | 2021-01-01 → 2021-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥467m | 2020-01-01 → 2020-12-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥40.8bn | at 2024-12-31 | Standalone | Assets |
| Total assets | ¥23.9bn | at 2023-12-31 | Standalone | Assets |
| Total assets | ¥20.5bn | at 2022-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥18.8bn | at 2021-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥15.4bn | at 2020-12-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥19.6bn | at 2024-12-31 | Standalone | Liabilities |
| Total liabilities | ¥5.9bn | at 2023-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥21.3bn | at 2024-12-31 | Standalone | Net assets |
| Net assets / equity | ¥18.1bn | at 2023-12-31 | Standalone | Net assets |
| Net assets / equity | ¥15.4bn | at 2022-12-31d | Standalone | Net assets |
| Net assets / equity | ¥14.1bn | at 2021-12-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥9.7bn | at 2020-12-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥14.2bn | at 2024-12-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥14.0bn | at 2023-12-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥94.35 | 2024-01-01 → 2024-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥84.95 | 2023-01-01 → 2023-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥37.48 | 2022-01-01 → 2022-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥20.64 | 2021-01-01 → 2021-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥16.09 | 2020-01-01 → 2020-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥93.75 | 2024-01-01 → 2024-12-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥83.9 | 2023-01-01 → 2023-12-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥36.75 | 2022-01-01 → 2022-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥19.9 | 2021-01-01 → 2021-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥14.85 | 2020-01-01 → 2020-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥653.79 | at 2024-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥557.89 | at 2023-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥479.42 | at 2022-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥441.63 | at 2021-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥314.91 | at 2020-12-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 52.1% | at 2024-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 75.5% | at 2023-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 75.1% | at 2022-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.7% | at 2021-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 63.0% | at 2020-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 15.6% | 2024-01-01 → 2024-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 16.4% | 2023-01-01 → 2023-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 8.1% | 2022-01-01 → 2022-12-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 5.5% | 2021-01-01 → 2021-12-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.2% | 2020-01-01 → 2020-12-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 32,738,600 | at 2024-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 32,738,600 | at 2023-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 32,706,800 | at 2022-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 32,462,500 | at 2021-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 30,889,100 | at 2020-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 1,042 | at 2024-12-31 | Standalone | Number of employees |
| Employees | 822 | at 2023-12-31 | Standalone | Number of employees |
| Employees | 699 | at 2022-12-31d | Standalone | Number of employees |
| Employees | 589 | at 2021-12-31d | Standalone | Number of employees |
| Employees | 474 | at 2020-12-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 69
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2024-01-01 → 2024-12-31 | ¥55m |
| Reconciling Itemsreconciling | depreciation | 2024-01-01 → 2024-12-31 | ¥109m |
| Reconciling Itemsreconciling | revenue | 2024-01-01 → 2024-12-31 | −¥4m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-01-01 → 2024-12-31 | −¥4m |
| Reconciling Itemsreconciling | segment assets | at 2024-12-31 | ¥27.9bn |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-12-31 | −¥5.0bn |
| Medical Platform Businessreportable segment | capex | 2024-01-01 → 2024-12-31 | ¥1.9bn |
| Medical Platform Businessreportable segment | depreciation | 2024-01-01 → 2024-12-31 | ¥212m |
| Medical Platform Businessreportable segment | employees | at 2024-12-31 | 557 pure |
| Medical Platform Businessreportable segment | revenue | 2024-01-01 → 2024-12-31 | ¥7.3bn |
| Medical Platform Businessreportable segment | revenue external | 2024-01-01 → 2024-12-31 | ¥7.3bn |
| Medical Platform Businessreportable segment | segment assets | at 2024-12-31 | ¥6.0bn |
| Medical Platform Businessreportable segment | segment profit | 2024-01-01 → 2024-12-31 | −¥95m |
| New Development Servicesreportable segment | depreciation | 2024-01-01 → 2024-12-31 | ¥35m |
| New Development Servicesreportable segment | employees | at 2024-12-31 | 96 pure |
| New Development Servicesreportable segment | revenue | 2024-01-01 → 2024-12-31 | ¥849m |
| New Development Servicesreportable segment | revenue external | 2024-01-01 → 2024-12-31 | ¥849m |
| New Development Servicesreportable segment | segment assets | at 2024-12-31 | ¥374m |
| New Development Servicesreportable segment | segment profit | 2024-01-01 → 2024-12-31 | −¥296m |
| Recruitment Platform Businessreportable segment | capex | 2024-01-01 → 2024-12-31 | ¥11.2bn |
| Recruitment Platform Businessreportable segment | depreciation | 2024-01-01 → 2024-12-31 | ¥546m |
| Recruitment Platform Businessreportable segment | employees | at 2024-12-31 | 617 pure |
| Recruitment Platform Businessreportable segment | revenue | 2024-01-01 → 2024-12-31 | ¥21.1bn |
| Recruitment Platform Businessreportable segment | revenue external | 2024-01-01 → 2024-12-31 | ¥21.1bn |
| Recruitment Platform Businessreportable segment | revenue intersegment | 2024-01-01 → 2024-12-31 | ¥4m |
| Recruitment Platform Businessreportable segment | segment assets | at 2024-12-31 | ¥10.9bn |
| Recruitment Platform Businessreportable segment | segment profit | 2024-01-01 → 2024-12-31 | ¥7.7bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2024-01-01 → 2024-12-31 | ¥13.1bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2024-01-01 → 2024-12-31 | ¥794m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-01-01 → 2024-12-31 | ¥29.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-01-01 → 2024-12-31 | ¥29.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-01-01 → 2024-12-31 | ¥4m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2024-12-31 | ¥17.3bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-01-01 → 2024-12-31 | ¥7.3bn |
| Reconciling Itemsreconciling | capex | 2023-01-01 → 2023-12-31 | ¥105m |
| Reconciling Itemsreconciling | depreciation | 2023-01-01 → 2023-12-31 | ¥23m |
| Reconciling Itemsreconciling | revenue | 2023-01-01 → 2023-12-31 | −¥2m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-01-01 → 2023-12-31 | −¥2m |
| Reconciling Itemsreconciling | segment assets | at 2023-12-31 | ¥21.9bn |
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-12-31 | −¥2.9bn |
| Medical Platform Businessreportable segment | capex | 2023-01-01 → 2023-12-31 | ¥620m |
| Medical Platform Businessreportable segment | depreciation | 2023-01-01 → 2023-12-31 | ¥163m |
| Medical Platform Businessreportable segment | revenue | 2023-01-01 → 2023-12-31 | ¥5.5bn |
| Medical Platform Businessreportable segment | revenue external | 2023-01-01 → 2023-12-31 | ¥5.5bn |
| Medical Platform Businessreportable segment | segment assets | at 2023-12-31 | ¥2.4bn |
| Medical Platform Businessreportable segment | segment profit | 2023-01-01 → 2023-12-31 | −¥383m |
| New Development Servicesreportable segment | capex | 2023-01-01 → 2023-12-31 | ¥519m |
| New Development Servicesreportable segment | depreciation | 2023-01-01 → 2023-12-31 | ¥26m |
| New Development Servicesreportable segment | revenue | 2023-01-01 → 2023-12-31 | ¥420m |
| New Development Servicesreportable segment | revenue external | 2023-01-01 → 2023-12-31 | ¥420m |
| New Development Servicesreportable segment | segment assets | at 2023-12-31 | ¥477m |
| New Development Servicesreportable segment | segment profit | 2023-01-01 → 2023-12-31 | −¥349m |
| Recruitment Platform Businessreportable segment | capex | 2023-01-01 → 2023-12-31 | ¥179m |
| Recruitment Platform Businessreportable segment | depreciation | 2023-01-01 → 2023-12-31 | ¥203m |
| Recruitment Platform Businessreportable segment | revenue | 2023-01-01 → 2023-12-31 | ¥14.7bn |
| Recruitment Platform Businessreportable segment | revenue external | 2023-01-01 → 2023-12-31 | ¥14.7bn |
| Recruitment Platform Businessreportable segment | revenue intersegment | 2023-01-01 → 2023-12-31 | ¥2m |
| Recruitment Platform Businessreportable segment | segment assets | at 2023-12-31 | ¥700m |
| Recruitment Platform Businessreportable segment | segment profit | 2023-01-01 → 2023-12-31 | ¥6.3bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2023-01-01 → 2023-12-31 | ¥1.3bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2023-01-01 → 2023-12-31 | ¥393m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-01-01 → 2023-12-31 | ¥20.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-01-01 → 2023-12-31 | ¥20.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-01-01 → 2023-12-31 | ¥2m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2023-12-31 | ¥3.5bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-01-01 → 2023-12-31 | ¥5.6bn |
| Medical Platform Businessreportable segment | employees | at 2024-12-31 | 220 pure |
| New Development Servicesreportable segment | employees | at 2024-12-31 | 51 pure |
| Recruitment Platform Businessreportable segment | employees | at 2024-12-31 | 564 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,431
| Item | Context | Value | Unit |
|---|---|---|---|
| Net sales | CurrentYearDuration_jpcrp030000-asr_E33586-000NewDevelopmentServicesReportableSegmentMember | 849000000 | JPY |
| Net sales | CurrentYearDuration_TotalOfReportableSegmentsAndOthersMember | 29306000000 | JPY |
| Net sales | CurrentYearDuration_ReconcilingItemsMember | -4000000 | JPY |
| Net sales | CurrentYearDuration | 29302000000 | JPY |
| Operating income | CurrentYearDuration_jpcrp030000-asr_E33586-000RecruitmentPlatformBusinessReportableSegmentMember | 7723000000 | JPY |
| Operating income | CurrentYearDuration_jpcrp030000-asr_E33586-000MedicalPlatformBusinessReportableSegmentMember | -95000000 | JPY |
| Operating income | CurrentYearDuration_jpcrp030000-asr_E33586-000NewDevelopmentServicesReportableSegmentMember | -296000000 | JPY |
| Operating income | CurrentYearDuration_TotalOfReportableSegmentsAndOthersMember | 7331000000 | JPY |
| Operating income | CurrentYearDuration_ReconcilingItemsMember | -5004000000 | JPY |
| Operating income | CurrentYearDuration | 2326000000 | JPY |
| Assets | CurrentYearInstant_jpcrp030000-asr_E33586-000RecruitmentPlatformBusinessReportableSegmentMember | 10898000000 | JPY |
| Assets | CurrentYearInstant_jpcrp030000-asr_E33586-000MedicalPlatformBusinessReportableSegmentMember | 5996000000 | JPY |
| Assets | CurrentYearInstant_jpcrp030000-asr_E33586-000NewDevelopmentServicesReportableSegmentMember | 374000000 | JPY |
| Assets | CurrentYearInstant_TotalOfReportableSegmentsAndOthersMember | 17269000000 | JPY |
| Assets | CurrentYearInstant_ReconcilingItemsMember | 27932000000 | JPY |
| Assets | CurrentYearInstant | 45201000000 | JPY |
| Depreciation segment information | CurrentYearDuration_jpcrp030000-asr_E33586-000RecruitmentPlatformBusinessReportableSegmentMember | 546000000 | JPY |
| Depreciation segment information | CurrentYearDuration_jpcrp030000-asr_E33586-000MedicalPlatformBusinessReportableSegmentMember | 212000000 | JPY |
| Depreciation segment information | CurrentYearDuration_jpcrp030000-asr_E33586-000NewDevelopmentServicesReportableSegmentMember | 35000000 | JPY |
| Depreciation segment information | CurrentYearDuration_TotalOfReportableSegmentsAndOthersMember | 794000000 | JPY |
| Depreciation segment information | CurrentYearDuration_ReconcilingItemsMember | 109000000 | JPY |
| Depreciation segment information | CurrentYearDuration | 903000000 | JPY |
| Amortization of goodwill sga | CurrentYearDuration_jpcrp030000-asr_E33586-000RecruitmentPlatformBusinessReportableSegmentMember | 470000000 | JPY |
| Amortization of goodwill sga | CurrentYearDuration_jpcrp030000-asr_E33586-000MedicalPlatformBusinessReportableSegmentMember | 245000000 | JPY |
| Amortization of goodwill sga | CurrentYearDuration_jpcrp030000-asr_E33586-000NewDevelopmentServicesReportableSegmentMember | 57000000 | JPY |
| Amortization of goodwill sga | CurrentYearDuration_TotalOfReportableSegmentsAndOthersMember | 773000000 | JPY |
| Amortization of goodwill sga | CurrentYearDuration_ReconcilingItemsMember | － | JPY |
| Amortization of goodwill sga | CurrentYearDuration | 773000000 | JPY |
| Increase in property plant and equipment and intangible assets | CurrentYearDuration_jpcrp030000-asr_E33586-000RecruitmentPlatformBusinessReportableSegmentMember | 11203000000 | JPY |
| Increase in property plant and equipment and intangible assets | CurrentYearDuration_jpcrp030000-asr_E33586-000MedicalPlatformBusinessReportableSegmentMember | 1871000000 | JPY |
| Increase in property plant and equipment and intangible assets | CurrentYearDuration_jpcrp030000-asr_E33586-000NewDevelopmentServicesReportableSegmentMember | － | JPY |
| Increase in property plant and equipment and intangible assets | CurrentYearDuration_TotalOfReportableSegmentsAndOthersMember | 13075000000 | JPY |
| Increase in property plant and equipment and intangible assets | CurrentYearDuration_ReconcilingItemsMember | 55000000 | JPY |
| Increase in property plant and equipment and intangible assets | CurrentYearDuration | 13130000000 | JPY |
| Goodwill before offsetting | Prior1YearInstant_jpcrp030000-asr_E33586-000RecruitmentPlatformBusinessReportableSegmentMember | 273000000 | JPY |
| Goodwill before offsetting | Prior1YearInstant_jpcrp030000-asr_E33586-000MedicalPlatformBusinessReportableSegmentMember | 949000000 | JPY |
| Goodwill before offsetting | Prior1YearInstant_jpcrp030000-asr_E33586-000NewDevelopmentServicesReportableSegmentMember | 268000000 | JPY |
| Goodwill before offsetting | Prior1YearInstant_ReportableSegmentsMember | 1491000000 | JPY |
| Goodwill before offsetting | Prior1YearInstant_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Goodwill before offsetting | Prior1YearInstant_UnallocatedAmountsAndEliminationMember | － | JPY |
| Goodwill before offsetting | Prior1YearInstant | 1491000000 | JPY |
| Goodwill before offsetting | CurrentYearInstant_jpcrp030000-asr_E33586-000RecruitmentPlatformBusinessReportableSegmentMember | 4640000000 | JPY |
| Goodwill before offsetting | CurrentYearInstant_jpcrp030000-asr_E33586-000MedicalPlatformBusinessReportableSegmentMember | 3024000000 | JPY |
| Goodwill before offsetting | CurrentYearInstant_jpcrp030000-asr_E33586-000NewDevelopmentServicesReportableSegmentMember | 211000000 | JPY |
| Goodwill before offsetting | CurrentYearInstant_ReportableSegmentsMember | 7876000000 | JPY |
| Goodwill before offsetting | CurrentYearInstant_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Goodwill before offsetting | CurrentYearInstant_UnallocatedAmountsAndEliminationMember | － | JPY |
| Goodwill before offsetting | CurrentYearInstant | 7876000000 | JPY |
| Cash and deposits | Prior1YearInstant_NonConsolidatedMember | 14005000000 | JPY |
| Cash and deposits | CurrentYearInstant_NonConsolidatedMember | 14235000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |